Skip to main content
. Author manuscript; available in PMC: 2016 Aug 29.
Published in final edited form as: Exp Hematol. 2013 Oct 2;42(1):39–45. doi: 10.1016/j.exphem.2013.09.012

Table 1.

Patient Characteristics

Variable Auto-SCT
(n=198)
Allo-SCT
(n=72)

Male 127 (64%) 43 (60%)
Female 71 (36%) 29 (40%)

Median age 52 (22–71) 47 (22–65)

B-cell 176 (89%) 62 (86%)
T-cell 22 (11%) 10 (14%)

B-cell Indolent 19 (25%) 30 (48.2%)
B cell aggressive 157 (75%) 32 (51.8%)

Stage
I/II 53 (27%) 11 (15%)
III/IV 145 (73%) 61 (85%)

Number of prior regimens
≤2 128 (65%) 30 (42%)
>2 70 (35%) 42 (58%)

Disease status prior to transplant
CR 142 (70%) 40 (56%)
PR/ SD 56 (29%) 32 (44%)

Prior radiation Yes 19 (10%) 15 (20%)

MRD - 45
Unrelated stem cell source - 27
RIC - 49 (68%)
MST - 23 (32%)